Summary

The dermatology devices market is valued at around USD 9.32 billion in 2026 and is expected to reach USD 17.73 billion by 2031, reflecting a CAGR of 13.7% over the forecast period. The rising prevalence of skin disorders, including skin cancer, acne, psoriasis, and pigmentation disorders, along with growing demand for minimally invasive and non-invasive aesthetic procedures, is driving adoption of advanced dermatology devices. Ongoing advancements in laser, radiofrequency, HIFU, light-based, and imaging technologies are improving treatment precision, safety, and clinical outcomes, further supporting market growth. The growing aging population, increasing beauty consciousness influenced by social media, rising disposable incomes, and the expansion of dermatology clinics and aesthetic centers are also contributing to the adoption of dermatology devices worldwide.

“The imaging devices segment is expected to witness the fastest growth rate in the dermatology devices market, by diagnostic device type, during the forecast period.”
Based on diagnostic device type, the dermatology devices market is segmented into imaging devices, dermatoscopes, and microscopes. During the forecast period, the imaging devices segment is expected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by the increasing adoption of advanced, non-invasive imaging technologies for the early detection, diagnosis, and monitoring of skin disorders. The growing use of optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and other high-resolution imaging systems enables real-time visualization of skin structures, improving diagnostic accuracy while reducing the need for invasive biopsies in many cases. Furthermore, continuous technological advancements, the rising incidence of skin cancer and other dermatological conditions, increasing demand for precise image-guided diagnosis, and growing adoption of advanced diagnostic technologies in dermatology clinics and hospitals are expected to drive rapid growth in this segment during the forecast period.

“The treatment devices segment accounted for the largest share of the dermatology devices market, by type, in 2025.”
By type, the dermatology devices market is segmented into diagnostic and treatment devices. In 2025, the treatment devices segment accounted for the largest share of the dermatology devices market. This dominance is driven by rising demand for both aesthetic and therapeutic dermatology procedures, the growing prevalence of chronic and cosmetic skin conditions such as acne, psoriasis, skin cancer, and pigmentation disorders, and a growing preference for minimally invasive and non-invasive treatment options. Additionally, ongoing advances in laser, radiofrequency, HIFU, cryotherapy, and other energy-based technologies have improved treatment precision, safety, and clinical outcomes, leading to their widespread adoption. The expanding network of dermatology and cosmetic clinics, growing consumer awareness of aesthetic treatments, rising disposable incomes, and increasing acceptance of cosmetic procedures are further supporting the growth of the treatment devices segment.

“The Asia Pacific region is expected to witness the fastest growth in the dermatology devices market during the forecast period.”
By region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is projected to register the highest CAGR in the dermatology devices market. This growth is primarily driven by rapid economic development, rising disposable incomes, and expanding access to healthcare across emerging economies such as China, India, Indonesia, and Thailand. The region's large and growing population, increasing prevalence of skin disorders, rising awareness of dermatological and aesthetic treatments, and growing demand for minimally invasive procedures further support market growth. Furthermore, the expanding middle-class population, increasing investments in healthcare infrastructure, rapid growth in dermatology and aesthetic clinics, continuous adoption of advanced dermatology technologies, and the growing popularity of medical tourism in countries such as South Korea and Thailand are expected to accelerate growth in the Asia Pacific dermatology devices market during the forecast period.

The breakup of the profile of primary participants in the dermatology devices market:
・By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
・By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
・By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the dermatology devices market include Bausch Health Companies Inc. (Canada), Sisram Medical Ltd. (Israel), AbbVie Inc. (US), InMode Ltd. (Israel), BTL Group of Companies (Czech Republic), El.En. S.p.A. (Italy), Cutera, Inc. (US), Lumenis Be Ltd. (Israel), Cynosure Lutronic (US), Candela Corporation (US), Jeisys Medical Inc. (South Korea), HEINE Optotechnik GmbH & Co. KG (Germany), Canfield Scientific, Inc. (US), Michelson Diagnostics (UK), Genesis Biosystems, Inc. (US), FotoFinder Systems GmbH (Germany), Beijing Toplaser Technology Co., Ltd. (China), Aerolase (US), GIGAAMEDICAL (China), Dimed Laser (China), Sciton (US), Fotona (US), Lynton Lasers Ltd. (UK), Astanza Laser (US), and Courage+Khazaka electronic GmbH (Germany).

Research Coverage:
This research report categorizes the dermatology devices market by Type [Diagnostic Devices (Imaging Devices, Dermatoscopes, and Microscopes), Treatment Devices (Light Therapy Devices, Lasers, Electrosurgical Equipment, Liposuction Devices, Microdermabrasion Devices, Cryotherapy Devices, Radiofrequency Devices, and HIFU (High-Intensity Focused Ultrasound) Devices)], by Application [Diagnostic Applications (Skin Cancer Diagnosis, Inflammatory Skin Disease Diagnosis, Hair & Scalp Disorder Diagnosis, and Other Diagnostic Applications), Medical Therapeutic Applications (Skin Cancer Treatment, Acne & Psoriasis Treatment, Vascular & Pigmented Lesion Treatment, and Other Medical Therapeutic Applications), and Aesthetic Therapeutic Applications (Hair Removal, Skin Rejuvenation & Anti-aging, Wrinkle Removal & Skin Resurfacing, Body Contouring & Fat Removal, Tattoo Removal, and Other Aesthetic Therapeutic Applications)], by Technology (Laser-Based, Ultrasound-Based, Light-Based, Cryotherapy-Based, RF-Based, and Other Technologies), by End User (Hospitals, Dermatology Clinics & Medical Facilities, Beauty Centers, and Home Care Settings), and by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides a comprehensive overview of the key drivers, restraints, opportunities, and challenges shaping growth in the dermatology devices market. It offers an in-depth analysis of the major industry players, highlighting their business models, solutions, key strategies, recent acquisitions, and agreements. Additionally, the report includes a competitive analysis of emerging startups in the dermatology devices market.
Reasons to Buy this Report:
The report will assist market leaders and new entrants in the dermatology devices industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
・Analysis of key drivers (rising prevalence of skin disorders and skin cancer, increasing demand for minimally invasive and noninvasive aesthetic procedures, growing aging population and rising burden of age-related skin conditions, and growing beauty consciousness, social media influence, and emphasis on personal appearance), restraints (stringent regulatory requirements for medical devices, risk of procedure-related adverse events and complications), opportunities (expansion of dermatology services in emerging markets, increasing disposable income and expanding middle-class population), and challenges (competitive pricing by low-cost manufacturers, high cost of advanced dermatology devices and limited reimbursement for aesthetic procedures) influencing the growth of the dermatology devices market
・Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the dermatology devices market
・Market Development: Comprehensive information about lucrative markets; the report analyzes the dermatology devices market across varied regions
・Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market
・Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Bausch Health Companies Inc. (Canada), Sisram Medical Ltd (Israel), Lumenis Be Ltd. (Israel), InMode Ltd. (Israel), and BTL Group of Companies (Czech Republic)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 37
1.3 STUDY SCOPE 37
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 37
1.3.2 INCLUSIONS AND EXCLUSIONS 38
1.3.3 YEARS CONSIDERED 39
1.4 CURRENCY CONSIDERED 39
1.5 STAKEHOLDERS 39
1.6 SUMMARY OF CHANGES 40
2 EXECUTIVE SUMMARY 41
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 41
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 42
2.3 DISRUPTIVE TRENDS SHAPING MARKET 43
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 44
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 45
3 PREMIUM INSIGHTS 46
3.1 DERMATOLOGY DEVICES MARKET OVERVIEW 46
3.2 DERMATOLOGY DEVICES MARKET, BY TYPE, 2026 VS. 2031 47
3.3 DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2026 VS. 2031 47
3.4 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY, 2026 VS. 2031 48
3.5 DERMATOLOGY DEVICES MARKET, BY END USER, 2026 VS. 2031 48
3.6 DERMATOLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
4 MARKET OVERVIEW 50
4.1 INTRODUCTION 50
4.2 MARKET DYNAMICS 50
4.2.1 DRIVERS 51
4.2.1.1 Rising prevalence of skin disorders and skin cancer 51
4.2.1.2 Increasing demand for minimally invasive and non-invasive aesthetic procedures 51
4.2.1.3 Growing aging population and rising burden of age-related skin conditions 52
4.2.1.4 Growing beauty consciousness, social media influence, and emphasis on personal appearance 53
4.2.2 RESTRAINTS 53
4.2.2.1 Stringent regulatory requirements for medical devices 53
4.2.2.2 Risk of procedure-related adverse events and complications 54
4.2.3 OPPORTUNITIES 54
4.2.3.1 Expansion of dermatology services in emerging markets 54
4.2.3.2 Increasing disposable income and expanding middle-class population 54
4.2.4 CHALLENGES 55
4.2.4.1 Competitive pricing by low-cost manufacturers 55
4.2.4.2 High cost of advanced dermatology devices and limited reimbursement for aesthetic procedures 55
4.3 UNMET NEEDS AND WHITE SPACES 56
4.3.1 UNMET NEEDS IN DERMATOLOGY DEVICES MARKET 56
4.3.2 WHITE SPACE OPPORTUNITIES 57
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 58
4.4.1 INTERCONNECTED MARKETS 58
4.4.2 CROSS-SECTOR OPPORTUNITIES 59
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 60
4.5.1 KEY MOVES AND STRATEGIC FOCUS 60
5 INDUSTRY TRENDS 61
5.1 PORTER’S FIVE FORCES ANALYSIS 61
5.1.1 BARGAINING POWER OF SUPPLIERS 62
5.1.2 BARGAINING POWER OF BUYERS 62
5.1.3 THREAT OF NEW ENTRANTS 62
5.1.4 THREAT OF SUBSTITUTES 62
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 63
5.2 MACROECONOMIC INDICATORS 63
5.2.1 INTRODUCTION 63
5.2.2 GDP TRENDS AND FORECAST 63
5.3 SUPPLY CHAIN ANALYSIS 66
5.4 VALUE CHAIN ANALYSIS 67
5.5 ECOSYSTEM ANALYSIS 69
5.5.1 DERMATOLOGY DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 70
5.6 PRICING ANALYSIS 70
5.6.1 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY KEY PLAYER, 2024–2026 70
5.6.2 AVERAGE SELLING PRICE OF DERMATOLOGY DEVICES, BY REGION, 2024–2026 71
5.7 TRADE ANALYSIS 72
5.7.1 IMPORT SCENARIO (HS CODE 901320) 72
5.7.2 EXPORT SCENARIO (HS CODE 901320) 73
5.8 KEY CONFERENCES & EVENTS, 2026–2027 73
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74
5.10 INVESTMENT & FUNDING SCENARIO 75
5.11 IMPACT OF 2025 US TARIFF ON DERMATOLOGY DEVICES MARKET 75
5.11.1 INTRODUCTION 75
5.11.2 KEY TARIFF RATES 76
5.11.3 PRICE IMPACT ANALYSIS 76
5.11.4 IMPACT ON REGION 77
5.11.4.1 North America 77
5.11.4.2 Europe 77
5.11.4.3 Asia Pacific 78
5.11.5 IMPACT ON END-USE INDUSTRIES 78
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 79
6.1 KEY EMERGING TECHNOLOGIES 79
6.1.1 LASER TECHNOLOGIES 79
6.1.2 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) 79
6.2 COMPLEMENTARY TECHNOLOGIES 80
6.2.1 TELEDERMATOLOGY PLATFORMS 80
6.2.2 ADVANCED CRYOGEN COOLING & SKIN COOLING TECHNOLOGIES 80
6.3 ADJACENT TECHNOLOGIES 81
6.3.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) 81
6.3.2 3D SKIN IMAGING & COMPUTER VISION 81
6.4 TECHNOLOGY/PRODUCT ROADMAP 82
6.5 PATENT ANALYSIS 83
6.5.1 LIST OF MAJOR PATENTS 84
6.5.2 LIST OF KEY PATENTS 84
6.6 FUTURE APPLICATIONS 85
6.7 IMPACT OF AI/GENERATIVE AI ON DERMATOLOGY DEVICES MARKET 86
6.7.1 INTRODUCTION 86
6.7.2 TOP USE CASES AND MARKET POTENTIAL 87
6.7.3 KEY COMPANIES IMPLEMENTING AI 88
6.7.4 FUTURE OF AI 88
7 REGULATORY LANDSCAPE AND SUSTAINABILITY 89
7.1 REGIONAL REGULATIONS AND COMPLIANCE 89
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
7.2 SUSTAINABILITY INITIATIVES 91
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN DERMATOLOGY DEVICES 91
7.2.1.1 Eco-friendly Initiatives 92
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 92
 
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
8.1 DECISION-MAKING PROCESS 94
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 94
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
8.2.2 BUYING CRITERIA 95
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 96
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97
8.5 MARKET PROFITABILITY 98
8.5.1 REVENUE POTENTIAL 98
8.5.2 COST DYNAMICS 99
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 99
9 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE 101
9.1 INTRODUCTION 102
9.2 DIAGNOSTIC DEVICES 102
9.2.1 IMAGING DEVICES 104
9.2.1.1 MRI, Ultrasound, CT, and OCT widely used in dermatology
disease diagnosis 104
9.2.2 DERMATOSCOPES 106
9.2.2.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE
SEGMENT GROWTH 106
9.2.3 MICROSCOPES 109
9.2.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES — KEY FACTOR DRIVING SEGMENT GROWTH 109
9.3 TREATMENT DEVICES 111
9.3.1 LIGHT THERAPY DEVICES 113
9.3.1.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES TO DRIVE SEGMENT GROWTH 113
9.3.2 LASERS 115
9.3.2.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS 115
9.3.3 ELECTROSURGICAL EQUIPMENT 117
9.3.3.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH 117
9.3.4 LIPOSUCTION DEVICES 119
9.3.4.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH 119
9.3.5 MICRODERMABRASION DEVICES 121
9.3.5.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH 121
9.3.6 CRYOTHERAPY DEVICES 123
9.3.6.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ADOPTION 123
9.3.7 RADIOFREQUENCY DEVICES 125
9.3.7.1 Rising demand for minimally invasive skin rejuvenation driving RF devices segment 125
9.3.8 HIFU DEVICES 127
9.3.8.1 Growing demand for non-invasive skin lifting driving HIFU devices growth 127
9.3.9 OTHER DERMATOLOGY TREATMENT DEVICES 129
10 DERMATOLOGY DEVICES MARKET, BY APPLICATION 132
10.1 INTRODUCTION 133
10.2 DIAGNOSTIC APPLICATION 133
10.2.1 SKIN CANCER DIAGNOSIS 136
10.2.1.1 Growing emphasis on early melanoma detection to drive skin cancer diagnosis segment 136
10.2.2 INFLAMMATORY SKIN DISEASE DIAGNOSIS 138
10.2.2.1 Increasing prevalence of chronic inflammatory skin disorders to support market growth 138
10.2.3 HAIR & SCALP DISORDER DIAGNOSIS 140
10.2.3.1 Rising awareness of hair health and increasing cases of hair loss to drive demand 140
10.2.4 OTHER DIAGNOSTIC APPLICATIONS 142
10.3 MEDICAL THERAPEUTIC APPLICATIONS 144
10.3.1 SKIN CANCER TREATMENT 146
10.3.1.1 Increasing adoption of minimally invasive therapies to drive demand 146
10.3.2 ACNE & PSORIASIS TREATMENT 148
10.3.2.1 Growing preference for long-term, minimally invasive disease management to support market growth 148
10.3.3 VASCULAR & PIGMENTED LESION TREATMENT 150
10.3.3.1 Rising demand for precise cosmetic correction to accelerate device adoption 150
10.3.4 OTHER MEDICAL THERAPEUTIC APPLICATIONS 152
10.4 AESTHETIC THERAPEUTIC APPLICATIONS 154
10.4.1 HAIR REMOVAL 156
10.4.1.1 Long-lasting results continue to shift consumers toward laser-based hair removal 156
10.4.2 SKIN REJUVENATION & ANTI-AGING 158
10.4.2.1 Growing appearance consciousness and preventive aesthetic care to reshape treatment demand 158
10.4.3 WRINKLE REMOVAL & SKIN RESURFACING 160
10.4.3.1 Preference for visible results without surgery to accelerate procedure adoption 160
10.4.4 BODY CONTOURING & FAT REMOVAL 162
10.4.4.1 Growing body confidence trends to increase demand for non-surgical body sculpting 162
10.4.5 TATTOO REMOVAL 164
10.4.5.1 Changing lifestyle preferences and advances in laser technology to drive procedure demand 164
10.4.6 OTHER AESTHETIC THERAPEUTIC APPLICATIONS 166
11 DERMATOLOGY DEVICES MARKET, BY TECHNOLOGY 169
11.1 INTRODUCTION 170
11.2 LASER-BASED 170
11.2.1 HIGH PRECISION AND BROAD CLINICAL APPLICATIONS TO DRIVE LASER-BASED SEGMENT 170
11.3 ULTRASOUND-BASED 172
11.3.1 INCREASING ADOPTION OF NON-INVASIVE SKIN LIFTING PROCEDURES TO DRIVE ULTRASOUND-BASED SEGMENT 172
11.4 LIGHT-BASED 174
11.4.1 EXPANDING USE OF NON-LASER LIGHT THERAPIES TO SUPPORT LIGHT-BASED SEGMENT 174
11.5 CRYOTHERAPY-BASED 176
11.5.1 INCREASING PREFERENCE FOR RAPID, OFFICE-BASED LESION TREATMENT TO SUPPORT SEGMENT 176
11.6 RF-BASED 178
11.6.1 ADVANCEMENTS IN COLLAGEN REMODELING TECHNOLOGIES TO DRIVE RF-BASED SEGMENT 178
11.7 OTHER TECHNOLOGIES 180
12 DERMATOLOGY DEVICES MARKET, BY END USER 183
12.1 INTRODUCTION 184
12.2 HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES 184
12.2.1 INCREASING PATIENT PREFERENCE FOR SPECIALIZED DERMATOLOGY CARE TO DRIVE GROWTH OF SEGMENT 184
12.3 BEAUTY CENTERS 186
12.3.1 GROWING CONSUMER DEMAND FOR NON-INVASIVE AESTHETIC PROCEDURES TO DRIVE BEAUTY CENTERS SEGMENT 186
12.4 HOME CARE SETTINGS 188
12.4.1 GROWING AVAILABILITY OF PORTABLE AND EASY-TO-USE DEVICES TO SUPPORT THIS SEGMENT 188
13 DERMATOLOGY DEVICES MARKET, BY REGION 191
13.1 INTRODUCTION 192
13.2 NORTH AMERICA 192
13.2.1 US 198
13.2.1.1 High healthcare expenditure and technological innovation to drive market growth 198
13.2.2 CANADA 203
13.2.2.1 Growing aging population and preference for minimally invasive procedures driving market growth 203
13.3 EUROPE 207
13.3.1 GERMANY 212
13.3.1.1 Increasing demand for minimally invasive dermatology procedures to drive market growth 212
13.3.2 UK 217
13.3.2.1 Increasing skin cancer incidence to drive market growth 217
13.3.3 FRANCE 221
13.3.3.1 Growing social acceptance of medical aesthetic treatments to drive market growth 221
13.3.4 ITALY 226
13.3.4.1 Growing medical tourism for aesthetic procedures to drive market growth 226
13.3.5 SPAIN 230
13.3.5.1 Increasing preference for minimally invasive aesthetic treatments to drive market growth 230
13.3.6 REST OF EUROPE 235
13.4 ASIA PACIFIC 239
13.4.1 CHINA 245
13.4.1.1 Increasing availability of digital aesthetic consultation platforms to drive market growth 245
13.4.2 JAPAN 249
13.4.2.1 Growing demand for non-surgical aesthetic procedures to drive market growth 249
13.4.3 INDIA 253
13.4.3.1 Rising awareness and affordability of aesthetic treatments to drive market growth 253
13.4.4 REST OF ASIA PACIFIC 258
13.5 LATIN AMERICA 262
13.5.1 BRAZIL 267
13.5.1.1 Expanding medical tourism to drive market growth 267
13.5.2 MEXICO 272
13.5.2.1 Expanding medical aesthetics industry to drive market growth 272
13.5.3 REST OF LATIN AMERICA 276
13.6 MIDDLE EAST & AFRICA 281
14 COMPETITIVE LANDSCAPE 286
14.1 INTRODUCTION 286
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 286
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DERMATOLOGY DEVICES MARKET 286
14.3 REVENUE ANALYSIS, 2023–2025 288
14.4 MARKET SHARE ANALYSIS, 2025 289
14.4.1 MARKET SHARE ANALYSIS, 2025 289
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 291
14.5.1 STARS 291
14.5.2 EMERGING LEADERS 291
14.5.3 PERVASIVE PLAYERS 291
14.5.4 PARTICIPANTS 291
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 293
14.5.5.1 Company footprint 293
14.5.5.2 Region footprint 293
14.5.5.3 Type footprint 294
14.5.5.4 Application footprint 294
14.5.5.5 End user footprint 295
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 295
14.6.1 PROGRESSIVE COMPANIES 295
14.6.2 RESPONSIVE COMPANIES 295
14.6.3 DYNAMIC COMPANIES 296
14.6.4 STARTING BLOCKS 296
14.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 297
14.6.5.1 Detailed list of key startups/SMEs 297
14.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 298
14.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 298
14.7 COMPANY VALUATION & FINANCIAL METRICS 299
14.7.1 FINANCIAL METRICS 299
14.7.2 COMPANY VALUATION 299
14.8 BRAND/PRODUCT COMPARISON 300
14.9 COMPETITIVE SCENARIO 301
14.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 301
14.9.2 DEALS 303
14.9.2.1 Expansions 304
15 COMPANY PROFILES 305
15.1 KEY PLAYERS 305
15.1.1 BAUSCH HEALTH COMPANIES INC. 305
15.1.1.1 Business overview 305
15.1.1.2 Products offered 306
15.1.1.3 Recent developments 307
15.1.1.3.1 Product launches & approvals 307
15.1.1.3.2 Deals 307
15.1.1.4 MnM view 308
15.1.1.4.1 Right to win 308
15.1.1.4.2 Strategic choices 308
15.1.1.4.3 Weaknesses & competitive threats 308
15.1.2 SISRAM MEDICAL LTD 309
15.1.2.1 Business overview 309
15.1.2.2 Products offered 311
15.1.2.3 Recent developments 311
15.1.2.3.1 Product launches & approvals 311
15.1.2.4 MnM view 312
15.1.2.4.1 Right to win 312
15.1.2.4.2 Strategic choices 312
15.1.2.4.3 Weaknesses & competitive threats 312
15.1.3 LUMENIS BE LTD. 313
15.1.3.1 Business overview 313
15.1.3.2 Products offered 313
15.1.3.3 Recent developments 314
15.1.3.3.1 Product launches & approvals 314
15.1.3.3.2 Deals 314
15.1.3.4 MnM view 315
15.1.3.4.1 Right to win 315
15.1.3.4.2 Strategic choices 315
15.1.3.4.3 Weaknesses & competitive threats 315
15.1.4 INMODE LTD 316
15.1.4.1 Business overview 316
15.1.4.2 Products offered 317
15.1.4.3 Recent developments 318
15.1.4.3.1 Product launches & approvals 318
15.1.4.4 MnM view 319
15.1.4.4.1 Right to win 319
15.1.4.4.2 Strategic choices 319
15.1.4.4.3 Weaknesses & competitive threats 319
15.1.5 BTL GROUP OF COMPANIES 320
15.1.5.1 Business overview 320
15.1.5.2 Products offered 320
15.1.5.3 MnM view 321
15.1.5.3.1 Right to win 321
15.1.5.3.2 Strategic choices 321
15.1.5.3.3 Weaknesses & competitive threats 321
15.1.6 EL.EN. S.P.A. 322
15.1.6.1 Business overview 322
15.1.6.2 Products offered 324
15.1.6.3 Recent developments 324
15.1.6.3.1 Product launches & approvals 324
15.1.7 ABBVIE INC. 325
15.1.7.1 Business overview 325
15.1.7.2 Products offered 326
15.1.7.3 Recent developments 327
15.1.7.3.1 Product launches & approvals 327
15.1.8 CYNOSURE LUTRONIC 328
15.1.8.1 Business overview 328
15.1.8.2 Products offered 329
15.1.8.3 Recent developments 329
15.1.8.3.1 Product launches & approvals 329
15.1.8.3.2 Deals 330
15.1.9 CUTERA, INC. 331
15.1.9.1 Business overview 331
15.1.9.2 Products offered 332
15.1.9.3 Recent developments 332
15.1.9.3.1 Product launches & approvals 332
15.1.10 FOTONA 333
15.1.10.1 Business overview 333
15.1.10.2 Products offered 333
15.1.10.3 Recent developments 334
15.1.10.3.1 Expansions 334
15.2 OTHER PLAYERS 335
15.2.1 CANDELA CORPORATION 335
15.2.2 JEISYS MEDICAL INC. 336
15.2.3 AEROLASE 337
15.2.4 SCITON 338
15.2.5 ASTANZA LASER 339
15.2.6 HEINE OPTOTECHNIK GMBH & CO. KG 340
15.2.7 CANFIELD SCIENTIFIC, INC. 341
15.2.8 MICHELSON DIAGNOSTICS 342
15.2.9 GENESIS BIOSYSTEMS, INC 343
15.2.10 FOTOFINDER SYSTEMS GMBH 344
15.2.11 BEIJING TOPLASER TECHNOLOGY CO., LTD. 345
15.2.12 GIGAAMEDICAL 346
15.2.13 DIMED LASER 347
15.2.14 LYNTON LASERS LTD 347
15.2.15 COURAGE+KHAZAKA ELECTRONIC GMBH 349
16 RESEARCH METHODOLOGY 350
16.1 RESEARCH DATA 350
16.2 SECONDARY DATA 351
16.2.1 LIST OF SECONDARY SOURCES 351
16.2.1.1 Key data from secondary sources 352
16.2.2 PRIMARY DATA 352
16.2.2.1 List of primary sources 353
16.2.2.2 Key data from primary sources 353
16.2.2.3 Key industry insights 355
16.2.2.4 Breakdown of primary interviews 355
16.3 MARKET SIZE ESTIMATION 356
16.3.1 TOTAL MARKET SIZE: DERMATOLOGY DEVICE MARKET 356
16.3.2 BOTTOM-UP APPROACH 356
16.3.2.1 Approach 1: Revenue estimation of key players 356
16.3.2.2 Approach 2: Study of annual reports and investor presentations 357
16.3.2.3 Approach 3: Primary interviews 357
16.3.2.4 Growth forecast 357
16.3.2.5 CAGR projections 358
16.3.3 TOP-DOWN APPROACH 358
16.4 DATA TRIANGULATION 359
16.5 RESEARCH ASSUMPTIONS 360
16.5.1 STUDY-RELATED ASSUMPTIONS 360
16.6 STUDY ASSUMPTIONS 360
16.6.1 PARAMETRIC ASSUMPTIONS 361
16.6.2 GROWTH RATE ASSUMPTIONS 361
16.7 RESEARCH LIMITATIONS 362
16.8 RISK ASSESSMENT 362
17 APPENDIX 363
17.1 DISCUSSION GUIDE 363
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 367
17.3 CUSTOMIZATION OPTIONS 368
17.4 RELATED REPORTS 369
17.5 AUTHOR DETAILS 370